Recombinant Antibody to Inducible T-Cell Co Stimulator (ICOS) Homo sapiens (Human) Protein, Antibody, Assaykit, Service

CD278; AILIM; Inducible T-Cell Costimulator; Activation-Inducible Lymphocyte Immunomediatory Molecule

Add to Cart Distributors
Overview
Properties
  • SourceRecombinant monoclonal antibody preparation, Host Mouse
  • Ig Isotype IgG, Clone Number n/a
  • PurificationProtein A + Protein G affinity chromatography
  • LabelNone
  • Immunogen RPA777Hu01-Recombinant Inducible T-Cell Co Stimulator (ICOS)
  • Buffer Formulation0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
  • TraitsLiquid, Concentration 0.1-1mg/ml
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Recombinant Antibody to Inducible T-Cell Co Stimulator (ICOS) Packages (Simulation)
  • Recombinant Antibody to Inducible T-Cell Co Stimulator (ICOS) Packages (Simulation)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specifity

The antibody is a mouse monoclonal antibody raised against ICOS. It has been selected for its ability to recognize ICOS in immunohistochemical staining and western blotting.

Usage

Western blotting: 1:40-1:400
Immunohistochemistry: 1:40-1:200
Immunocytochemistry: 1:40-1:200
Flow cytometry: 0.2-2µL/106 cells
Optimal working dilutions must be determined by end user.

Storage

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Giveaways

Citations

  • Increased production of soluble inducible costimulator in patients with diffuse cutaneous systemic sclerosisPubmed: 23053221
  • Effect of soluble inducible costimulator level and its polymorphisms on age-related macular degeneration.Pubmed: 24083358
  • Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosisPubmed: 23024058
  • Inducible T‐cell co‐stimulator (ICOS) and ICOS ligand are novel players in the multiple‐myeloma microenvironmentPubmed:34954822
  • Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue DiseasesPubmed:35328257

Recommend products